Journals / Abant Tıp Dergisi / 2026 / Cilt: 15 Sayı: 2

The Role of HbA1c, CRP/Albumin, and Neutrophil/Lymphocyte Ratio in Predicting Mortality in Geriatric Patients with Diabetic Foot Ulcers

Kübra Erdoğan(Ankara Bilkent City Hospital, University of Health Sciences, Division of Geriatrics, Department of Internal Medicine)0000-0001-9193-5327
Arife Polat Düzgün(Ankara Bilkent City Hospital, University of Health Sciences, Department of General Surgery)0000-0002-5517-4150
Pages
207–218
Publication Date
2026-08-28
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: HbA1c may be an independent, practical, and easily accessible risk marker associated with in-hospital mortality in geriatric diabetic foot patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aimed to evaluate the association between laboratory-based metabolic, inflammatory, and nutritional markers and in-hospital mortality among patients aged 65 years and older with diabetic foot ulcers.
📊
Key Findings & Data:Materials and Methods: The retrospective study included 110 patients who were followed up for diabetic foot ulcers.
💡
Conclusion & Impact:Conclusion: HbA1c may be an independent, practical, and easily accessible risk marker associated with in-hospital mortality in geriatric diabetic foot patients.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Diabetic foot ulcer · HbA1c · in hospital mortality

Abstract

Objectives: This study aimed to evaluate the association between laboratory-based metabolic, inflammatory, and nutritional markers and in-hospital mortality among patients aged 65 years and older with diabetic foot ulcers. Materials and Methods: The retrospective study included 110 patients who were followed up for diabetic foot ulcers. Demographic characteristics, comorbidities, Wagner stage, length of stay, and routine laboratory parameters were recorded. The association of HbA1c, leukocyte count, neutrophil/lymphocyte ratio (NLR), CRP/albumin ratio (CAR), red blood cell distribution width (RDW), urea, and albumin levels with in-hospital mortality was evaluated. Patients discharged and those who died were compared. Factors associated with mortality were examined using logistic regression analysis, while discriminant performance was investigated using ROC analysis. Results: The median age of the patients was 73 years, and 67.3% were male. The median length of hospital stay was 23 days, and the median Wagner stage was 4. In-hospital mortality occurred in 24 patients (21.8%). In the death group, WBC, RDW, urea, and HbA1c levels were higher, and albumin levels were lower. The median HbA1c value was 7.50 in the discharge group and 9.90 in the death group. In multivariate analyses, HbA1c maintained its independent association with in-hospital mortality. In ROC analysis, HbA1c showed high discriminant performance (AUC: 0.944; 95% CI: 0.898–0.978; p<0.001). At a cutoff value of 8.80%, the sensitivity was 100%, the specificity was 86.0%, and the negative predictive value was 100%. Although numerically higher in the NLR and CAR death groups, this was not statistically significant. Conclusion: HbA1c may be an independent, practical, and easily accessible risk marker associated with in-hospital mortality in geriatric diabetic foot patients.

🔖

Cite This Article

Erdoğan, K., Düzgün, A. P. (2026). The Role of HbA1c, CRP/Albumin, and Neutrophil/Lymphocyte Ratio in Predicting Mortality in Geriatric Patients with Diabetic Foot Ulcers. Abant Tıp Dergisi, Cilt: 15 Sayı: 2, 207–218. https://doi.org/10.47493/abantmedj.1987136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: A review. JAMA. 2023;330(1):62-75.
  2. Monteiro-Soares M, Hamilton EJ, Russell DA, Srisawasdi G, Boyko EJ, Mills JL, et al. Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3648.
  3. Senneville É, Albalawi Z, van Asten SA, Abbas ZG, Allison G, Aragón-Sánchez J, et al. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023). Diabetes Metab Res Rev. 2024;40(3):e3687.
  4. Canpolat-Erkan RE, Tekin R, Ekinci A. Evaluation of neutrophil-to-lymphocyte ratio and CRP-to-albumin ratio in the risk stratification of diabetic foot infection severity. Medicina (Kaunas). 2026;62(2):393.
  5. Lane KL, Abusamaan MS, Voss BF, Thurber EG, Al-Hajri N, Gopakumar S, et al. Glycemic control and diabetic foot ulcer outcomes: A systematic review and meta-analysis of observational studies. J Diabetes Complications. 2020;34(10):107638.
  6. Fesseha BK, Abularrage CJ, Hines KF, Sherman R, Frost P, Langan S, et al. Association of hemoglobin A1c and wound healing in diabetic foot ulcers. Diabetes Care. 2018;41(7):1478-85.
  7. Sathvik M, Vuppuluri K, Dulipala P. The association of the neutrophil-lymphocyte ratio with the outcome of diabetic foot ulcer. Cureus. 2023;15(1):e33891.
  8. Karaca B, Ormen B, Kiris T, Sener A. Predictive value of C-reactive protein to albumin ratio for amputation risk in diabetic foot infection. Angiology. 2025;76(4):391-7.
  9. Hong J, Hu X, Liu W, Qian X, Jiang F, Xu Z, et al. Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: A retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):91.
  10. Guo Z, Yue C, Qian Q, He H, Mo Z. Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a Chinese tertiary care hospital. Int Wound J. 2019;16(6):1304-13.
  11. Chen W, Chen K, Xu Z, Hu Y, Liu Y, Liu W, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict mortality in patients with diabetic foot ulcers undergoing amputations. Diabetes Metab Syndr Obes. 2021;14:821-9.
  12. Xu S, Wang Y, Hu Z, Ma L, Zhang F, Liu P. Effects of neutrophil-to-lymphocyte ratio, serum calcium, and serum albumin on prognosis in patients with diabetic foot. Int Wound J. 2023;20(5):1638-46.
  13. van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, Monteiro-Soares M, et al. The International Working Group on the Diabetic Foot: Stories and numbers behind three decades of evidence-based guidelines for the management of diabetes-related foot disease. Diabetes Ther. 2024;15(1):19-31.
  14. Yoon YK, Park JH, Cho HH, Shim DW, Lee W, Han SH, et al. Red blood cell distribution width is an independent predictor of mortality following amputation for diabetic foot. Sci Rep. 2025;15(1):4441.
  15. Li R, Li C. Association between blood urea nitrogen concentration and diabetic foot ulcer: A retrospective cross-sectional study based on NHANES. Medicine (Baltimore). 2025;104(35):e44038.
  16. Di Martino G, Di Giovanni P, Cedrone F, Michela D, Meo F, Scampoli P, et al. The impact of COPD on hospitalized patients with diabetes: A propensity score matched analysis on discharge records. Healthcare (Basel). 2022;10(5):885.